[Remote] Territory Sales Specialist, Adults - Omaha, NE at Azurity Pharmaceuticals

Remote

Azurity Pharmaceuticals Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Skills

Key technologies and capabilities for this role

Pharmaceutical salesHealthcare salesStrategic business planningRelationship buildingCRM systemsData analysisSales strategyPhysician detailingPharmacy detailing

Questions & Answers

Common questions about this position

What qualifications are required for the Territory Sales Specialist role?

Candidates need a Bachelor’s degree, at least 2 years of Pharmaceutical or Healthcare Industry sales experience, demonstrated sales growth in managing a territory, business acumen, excellent organization and communication skills, proficiency in CRM tools like Veeva, and Microsoft Office.

Is this a remote position or does it require travel in the Omaha area?

The role is territory-based in Omaha, NE, involving a mix of in-person and virtual engagement, including calls on physicians, healthcare providers, and retail pharmacies, which implies travel within the geographical area.

What does Azurity Pharmaceuticals' company culture emphasize?

Azurity fosters an inclusive workplace with a talented, dedicated team focused on benefiting patients through the best science and commitment to quality, seeking highly motivated individuals with dedication, integrity, and creative spirit.

What is the salary or compensation for this position?

This information is not specified in the job description.

What makes a strong candidate for this Territory Sales Specialist position?

A strong candidate has a track record of consistently meeting or exceeding sales goals while managing their own territory, along with business acumen to articulate clinical sales messages and strong skills in organization, communication, and CRM usage.

Azurity Pharmaceuticals

Develops specialized formulations of medicines

About Azurity Pharmaceuticals

Azurity Pharmaceuticals develops specialized formulations of existing medicines to meet the needs of patients who are often overlooked by traditional pharmaceutical companies. Their products include oral suspensions and other forms that are easier to administer, particularly for those who have difficulty swallowing pills or need precise dosing. This focus on creating accessible and effective medications enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity serves healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines across various therapeutic areas, including cardiovascular, central nervous system, and oncology. Their goal is to improve patient outcomes by providing high-quality, innovative medicines tailored to specific medical conditions.

Woburn, MassachusettsHeadquarters
2000Year Founded
$182.2MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Hybrid Work Options
Professional Development Budget
Tuition Reimbursement
Wellness Program

Risks

Product recalls, like Zenzedi's, can damage brand reputation and cause financial losses.
Integration challenges from Slayback Pharma acquisition may disrupt operations.
Reliance on FDA approvals means regulatory delays could impact product launches.

Differentiation

Azurity focuses on innovative dose forms for overlooked patient needs.
Their FDA-approved products ensure safety and efficacy in specialized formulations.
Azurity's acquisition of Slayback Pharma enhances its development and launch capabilities.

Upsides

Growing demand for personalized medicine aligns with Azurity's specialized dose forms.
Increasing chronic diseases boost need for Azurity's innovative drug delivery systems.
FDA's focus on novel formulations benefits Azurity's product pipeline.

Land your dream remote job 3x faster with AI